Previous studies have highlighted the association between alterations in TP53, ATM, RAD51, and BAX and poor treatment outcomes in other malignancies [43, 44], but their precise contribution to radioresistance in gastric cancer remains poorly understood. The gene discussed is RAD51; the disease is gastric cancer.